Back
Meritage Homes Vs. Tandem Diabetes Care Industry Stock Comparison
Buy
66
MTH
Meritage Homes
Last Price:
172.76
Seasonality Move:
4.98%
Buy
75
TNDM
Tandem Diabetes Care
Last Price:
49.68
Seasonality Move:
17.33%
Buy
66
Meritage Homes (MTH)
is a Buy
Is Meritage Homes a Buy, Sell or Hold?
- The current Meritage Homes [MTH] share price is $174.58. The Score for MTH is 66, which is 32% above its historic median score of 50, and infers lower risk than normal.
- MTH is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
75
Tandem Diabetes Care (TNDM)
is a Buy
Is Tandem Diabetes Care a Buy, Sell or Hold?
- The current Tandem Diabetes Care [TNDM] share price is $51.39. The Score for TNDM is 75, which is 50% above its historic median score of 50, and infers lower risk than normal.
- TNDM is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
MTH Stock Price Chart
What is Meritage Homes's stock price today?
-
The Meritage Homes share price today is $174.58
The current trend is moderately bearish and MTH is experiencing slight buying pressure.
TNDM Stock Price Chart
What is Tandem Diabetes Care's stock price today?
-
The Tandem Diabetes Care share price today is $51.39
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and TNDM is experiencing slight buying pressure.
MTH Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 4.6 | Buy |
| Relative Strength Index (14 RSI): | 50.97 | Buy |
| Chaikin Money Flow: | 77562 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (160.87 - 183.23) | Buy |
| Bollinger Bands (100): | (154.74 - 173.84) | Buy |
TNDM Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 3.93 | Buy |
| Relative Strength Index (14 RSI): | 78.86 | Buy |
| Chaikin Money Flow: | 156222 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (34.8 - 46.86) | Buy |
| Bollinger Bands (100): | (24.01 - 38.39) | Buy |
MTH Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 181.44 | Sell |
| 20-day SMA: | 176.79 | Sell |
| 50-day SMA: | 166.99 | Buy |
| 200-day SMA: | 150.16 | Buy |
| 8-day EMA: | 179.56 | Sell |
| 20-day EMA: | 176.04 | Sell |
| 50-day EMA: | 169.26 | Buy |
| 200-day EMA: | 152.59 | Buy |
TNDM Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 47.19 | Buy |
| 20-day SMA: | 42.88 | Buy |
| 50-day SMA: | 36.65 | Buy |
| 200-day SMA: | 26.81 | Buy |
| 8-day EMA: | 47.52 | Buy |
| 20-day EMA: | 43.6 | Buy |
| 50-day EMA: | 37.98 | Buy |
| 200-day EMA: | 31.5 | Buy |
Meritage Homes Earnings Growth & MTH Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.08 per share, an increase next quarter of $0.42 per share, an increase this year of $0.47 per share, and an increase next year of $1.04 per share.
Tandem Diabetes Care Earnings Growth & TNDM Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.04 per share, a decrease next quarter of $0.04 per share, an increase this year of $0.15 per share, and an increase next year of $0.54 per share.
Meritage Homes Technical Analysis
| May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | May 17 | May 20 | May 21 | May 22 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 09 | 10 | 13 | 14 | 15 | 16 | 17 | 20 | 21 | 22 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Tandem Diabetes Care Technical Analysis
| May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | May 17 | May 20 | May 21 | May 22 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 09 | 10 | 13 | 14 | 15 | 16 | 17 | 20 | 21 | 22 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||